Taiwan
· Delayed Price · Currency is TWD Onyx Healthcare Statistics
Total Valuation
Onyx Healthcare has a market cap or net worth of TWD 4.41 billion. The enterprise value is 4.36 billion.
| Market Cap | 4.41B |
| Enterprise Value | 4.36B |
Important Dates
The last earnings date was Friday, November 7, 2025.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | Jul 3, 2025 |
Share Statistics
Onyx Healthcare has 39.07 million shares outstanding. The number of shares has increased by 0.23% in one year.
| Current Share Class | 39.07M |
| Shares Outstanding | 39.07M |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 12.04% |
| Owned by Institutions (%) | 0.02% |
| Float | 12.30M |
Valuation Ratios
The trailing PE ratio is 33.85.
| PE Ratio | 33.85 |
| Forward PE | n/a |
| PS Ratio | 3.20 |
| PB Ratio | 2.91 |
| P/TBV Ratio | 2.91 |
| P/FCF Ratio | 24.49 |
| P/OCF Ratio | 22.60 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.91, with an EV/FCF ratio of 24.20.
| EV / Earnings | 33.45 |
| EV / Sales | 3.16 |
| EV / EBITDA | 25.91 |
| EV / EBIT | 29.54 |
| EV / FCF | 24.20 |
Financial Position
The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.06 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 2.70 |
| Debt / FCF | 1.53 |
| Interest Coverage | 17.57 |
Financial Efficiency
Return on equity (ROE) is 8.65% and return on invested capital (ROIC) is 2.87%.
| Return on Equity (ROE) | 8.65% |
| Return on Assets (ROA) | 2.42% |
| Return on Invested Capital (ROIC) | 2.87% |
| Return on Capital Employed (ROCE) | 4.73% |
| Revenue Per Employee | 11.50M |
| Profits Per Employee | 1.09M |
| Employee Count | 117 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 3.07 |
Taxes
In the past 12 months, Onyx Healthcare has paid 17.46 million in taxes.
| Income Tax | 17.46M |
| Effective Tax Rate | 11.84% |
Stock Price Statistics
The stock price has decreased by -29.60% in the last 52 weeks. The beta is 0.28, so Onyx Healthcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -29.60% |
| 50-Day Moving Average | 118.78 |
| 200-Day Moving Average | 126.53 |
| Relative Strength Index (RSI) | 49.24 |
| Average Volume (20 Days) | 29,725 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Onyx Healthcare had revenue of TWD 1.38 billion and earned 130.44 million in profits. Earnings per share was 3.34.
| Revenue | 1.38B |
| Gross Profit | 465.18M |
| Operating Income | 81.57M |
| Pretax Income | 147.46M |
| Net Income | 130.44M |
| EBITDA | 96.34M |
| EBIT | 81.57M |
| Earnings Per Share (EPS) | 3.34 |
Balance Sheet
The company has 328.65 million in cash and 276.41 million in debt, giving a net cash position of 52.24 million or 1.34 per share.
| Cash & Cash Equivalents | 328.65M |
| Total Debt | 276.41M |
| Net Cash | 52.24M |
| Net Cash Per Share | 1.34 |
| Equity (Book Value) | 1.52B |
| Book Value Per Share | 38.90 |
| Working Capital | 418.89M |
Cash Flow
In the last 12 months, operating cash flow was 195.33 million and capital expenditures -15.06 million, giving a free cash flow of 180.27 million.
| Operating Cash Flow | 195.33M |
| Capital Expenditures | -15.06M |
| Free Cash Flow | 180.27M |
| FCF Per Share | 4.61 |
Margins
Gross margin is 33.71%, with operating and profit margins of 5.91% and 9.45%.
| Gross Margin | 33.71% |
| Operating Margin | 5.91% |
| Pretax Margin | 10.68% |
| Profit Margin | 9.45% |
| EBITDA Margin | 6.98% |
| EBIT Margin | 5.91% |
| FCF Margin | 13.06% |
Dividends & Yields
This stock pays an annual dividend of 3.96, which amounts to a dividend yield of 3.57%.
| Dividend Per Share | 3.96 |
| Dividend Yield | 3.57% |
| Dividend Growth (YoY) | -20.74% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 118.47% |
| Buyback Yield | -0.23% |
| Shareholder Yield | 3.34% |
| Earnings Yield | 2.95% |
| FCF Yield | 4.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 1, 2024. It was a forward split with a ratio of 1.1499016.
| Last Split Date | Aug 1, 2024 |
| Split Type | Forward |
| Split Ratio | 1.1499016 |
Scores
Onyx Healthcare has an Altman Z-Score of 6.68 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.68 |
| Piotroski F-Score | 6 |